Sykehuset i Vestfold
Tønsberg, Vestfold, Norway
5 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Urothelial Cancer
Bristol-Myers Squibb470 enrolled157 locationsNCT07106762
Recruiting
Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Pfizer492 enrolled273 locationsNCT06152575
Recruiting
Not Applicable
eBehandling - Health and Work for Patients in Specialist Mental Health Care
DepressionAnxiety
Solli Distriktspsykiatriske Senter400 enrolled9 locationsNCT06568419
Recruiting
Phase 3
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
Diffuse Large B Cell LymphomaDLBCL
Nordic Lymphoma Group300 enrolled69 locationsNCT04332822
Recruiting
NORDTREAT Prospective Study on Inflammatory Bowel Disease
Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Diseases (IBD)
University of Southern Denmark800 enrolled17 locationsNCT05414578